MartinWilliamSchoenMDMPH

Hematologic Oncology

Assistant Professor of Medicine, Saint Louis University

Dr. Schoen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
915 North Grand Blvd.
4th Floor
Saint Louis, MO 63106
Phone+1 314-289-6305

Fax+1 314-289-6320

Dr. Martin Schoen is a hematologist/oncologist at the St. Louis Veterans Affairs Medical Center and Saint Louis University specializes in the treatment of prostate cancer, hematologic malignancies, and breast cancer. His research focuses on outcomes, disparities, and adverse events using nationwide data available from the VA to personalize treatment of cancer.

SSM Health/Saint Louis University School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2013 - 2016
University of North Carolina at Chapel HillMPH, Health Policy and Management, 2008 - 2010
Harvard Medical SchoolClass of 2006

PubMed

Books/Book Chapters

Network Medicine: Complex Systems in Human Disease and Therapeutics
Chapter: Social Networks in Human Disease
Luke DA, Schoen MWEditors: Loscalzo J, Barabási AL, Silverman EK.Harvard University Press, Cambridge, MAEdition 1,2017
Pathophysiology of Heart Disease
Chapter: Cardiovascular Drugs
Schoen MW, Antman EM, Strichartz GR, Lilly LSEditors: Lilly, LS.Edition 4,2006

Abstracts/Posters

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine and Bendamustine
Schoen MW, Sanfilippo KM, Luo S, Mohammed KA, Carson KR, ASH 2017, Atlanta, GA, 12/2017
Acute Myeloid Leukemia Induction with Cladribine: Effects of Age and Leukemia Risk
Schoen MW, Woelich SK, Braun JT et. al, ASH 2016, San Diego, CA, 12/2016
Outcomes of Acute Myeloid Leukemia Induction with Addition of Cladribine
Schoen MW, Braun J, Woelich S, Ramlal R, Schmidt A, Freter CE, Lionberger JM, Missouri ACP, First Place Award: Research Poster, 9/1/2015
Usability Testing of the PRO-CTCAE Measurement System in Patients with Cancer
Fawzy MR, Abernethy AP, Schoen MW, et al., J Clin Oncol. 2013;e17560, ASCO 2013, 6/1/2013
Increased incidence of non-melanomatous skin cancer in patients with chronic lymphocytic leukemia, an 11-year case-control study
Schoen MW, Gable PS, Reese AM, ASCO 2007, Journal of Clinical Oncology 25, no. 18_suppl (June 2007) 19554-19554., 6/2007
Join now to see all

Lectures

Outcomes of Black Patients with Multiple Myeloma in the Veterans Health Administration
American Society of Hematology Annual Meeting - 12/3/2018
Association of venous thromboembolism with increased mortality in patients with multiple myeloma.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

SLU Researcher Reports Improvements in Survival Rates in Patients with Metastatic Prostate CancerJune 20th, 2024
SLU Researcher Reports Improvements in Survival Rates in Patients with Metastatic Prostate CancerJune 20th, 2024
Survival Edge Found Among Black US Veterans with mCRPCFebruary 17th, 2023
Join now to see all

Outcomes Researcher, Veterans AffairsI have conducted outcomes research in the Veterans Affairs to understand differences in treatment based on comorbidities and race.2016 - Present
Project Manager/ResearcherCenter for Public Health Systems Science at Washington University in St. Louis2012 - 2013
Student InvestigatorDivision of Sleep Medicine, Harvard Medical School2003 - 2006